AngioDynamics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
ANGO Nasdaq 3840 www.angiodynamics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AngioDynamics, Inc.

AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI - Jan 13th, 2025 1:00 pm
AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines - Jan 9th, 2025 2:48 pm
AngioDynamics Reports Growth and Advances NanoKnife System - Jan 9th, 2025 12:31 pm
AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Jan 9th, 2025 7:00 am
Q2 2025 AngioDynamics Inc Earnings Call - Jan 9th, 2025 5:31 am
AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates - Jan 8th, 2025 12:45 pm
AngioDynamics: Fiscal Q2 Earnings Snapshot - Jan 8th, 2025 11:39 am
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results - Jan 8th, 2025 11:30 am
AngioDynamics to Present at the J.P. Morgan Healthcare Conference - Jan 6th, 2025 2:26 pm
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System - Jan 6th, 2025 2:25 pm
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event - Dec 19th, 2024 10:00 pm
ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife - Dec 10th, 2024 4:14 pm
Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength? - Dec 10th, 2024 2:29 pm
NanoKnife gains FDA clearance for prostate tissue ablation - Dec 9th, 2024 6:03 pm
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation - Dec 9th, 2024 11:00 am
NARI Stock Likely to Gain Following Reimbursement Approval in Japan - Dec 3rd, 2024 4:20 pm
STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System - Nov 26th, 2024 4:07 pm
NVRO Stock Declines Despite Positive Study Data of Nevro1 System - Nov 19th, 2024 2:26 pm
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study - Nov 18th, 2024 3:55 pm
Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates - Nov 5th, 2024 3:28 pm